老百姓 (603883)

LBX Pharmacy Chain Joint Stock Company

ASH

Tags

MSCI Mid Cap IndexSSE 380 IndexPharmaceuticals and HealthcarePharmaceutical CommerceInvestments in Newly Listed CompaniesGuozheng Value IndexSmall Cap ValueNew RetailHigh-Performing StocksTencent ConceptFree Cash FlowMargin Trading and Securities LendingNorthbound Connect Heavy PositionsRetail

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 76009.56
  • Circulating A-Shares(W): 75889.02
  • Earnings Per Share(RMB): 0.7000
  • Net Assets Per Share(RMB): 8.9505
  • Operating Revenue(W RMB): 1607046.70
  • Total Profit(W RMB): 79327.51
  • **Net Profit Attributable to Parent(W RMB) **: 52864.72
  • Net Profit Growth Rate(%): -16.11
  • Weighted Return on Equity(%): 7.8300
  • Operating Cash Flow Per Share(RMB): 2.8380
  • Undistributed Profit Per Share(RMB): 5.2868
  • Capital Reserve Per Share(RMB): 2.2671

2. Main Business

The main business covers:

  • Engaged in the sales of pharmaceuticals and health-related products.

3. Company Basic Information

  • Company Name: Lao Bai Xing Drugstore Chain Joint Stock Co., Ltd.
  • Listing Date: 2015-04-23
  • Industry: Retail
  • Address: No. 808 Qingzhuhu Road, Kaifu District, Changsha City, Hunan Province
  • Website: https://www.lbxdrugs.com
  • Company Profile：The company's predecessor was Lao Bai Xing Drugstore Chain Co., Ltd. Hunan Lao Bai Xing Pharmaceutical Investment Management Co., Ltd., Chen Xiulan, and Shi Zhan held a meeting on November 1, 2005, agreeing to jointly establish Lao Bai Xing Co., Ltd. with a registered capital of 10 million RMB. On January 15, 2011, the board of directors of Lao Bai Xing Co., Ltd. agreed to convert the company into a joint stock company. On April 14, 2011, Lao Bai Xing held its founding meeting and reviewed and passed various resolutions related to the conversion into a joint stock company. All shareholders unanimously agreed that the company's total share capital would be based on the audited net assets of the parent company of Lao Bai Xing Co., Ltd. as of December 31, 2010, which amounted to 367,942,390 RMB, converted at a ratio of 54.35% into 200 million shares (par value of one RMB per share). The remaining balance of the audited net assets of the parent company of Lao Bai Xing Co., Ltd. after deducting the total share capital, 167,942,390 RMB, was converted into the company's capital reserve. On April 29, 2011, the company obtained the "Business License" (Registration No.: 430000000015859) issued by the Hunan Provincial Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Lao Bai Xing Pharmaceutical Group Co., Ltd. Corporate 18045.35 23.78
2 Zexing Investment Co., Ltd. Corporate 16801.30 22.14
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 775.58 1.02
4 Linzhi Tencent Technology Co., Ltd. Corporate 739.10 0.97
5 Southern China Securities 1000 ETF Fund 347.44 0.46
6 Guotai Medicine and Health Stock Securities Investment Fund Class A Fund 226.18 0.30
7 Guotai Great Health Stock Securities Investment Fund Class A Fund 106.25 0.14

5. Concept Sectors

  • New Retail
  • Tencent Concept
  • Margin Trading & Securities Lending
  • Blue Chip
  • Shareholding in New Listings
  • MSCI Mid Cap
  • Heavy Northbound Holdings
  • Free Cash Flow
  • SSE 380
  • Small Cap Value
  • SZSE Value

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information